Millennium Pharmacon International
PT Millennium Pharmacon International Tbk engages in the distribution of prescription and non-prescription medicines and medical devices in Indonesia. The company was formerly known as PT NVPD Soedarpo Corporation Tbk and changed its name to PT Millennium Pharmacon International Tbk in February 1990. The company was founded in 1952 and is headquartered in Jakarta Selatan, Indonesia. PT Millennium… Read more
Millennium Pharmacon International - Asset Resilience Ratio
Millennium Pharmacon International (SDPC) has an Asset Resilience Ratio of -0.72% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2021)
This chart shows how Millennium Pharmacon International's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Millennium Pharmacon International's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp0.00 | 0% |
| Short-term Investments | Rp-11.22 Billion | -0.72% |
| Total Liquid Assets | Rp-11.22 Billion | -0.72% |
Asset Resilience Insights
- Limited Liquidity: Millennium Pharmacon International maintains only -0.72% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Millennium Pharmacon International Industry Peers by Asset Resilience Ratio
Compare Millennium Pharmacon International's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950 |
Medical Distribution | 0.00% |
|
Shenzhen Glory Medical Co Ltd
SHE:002551 |
Medical Distribution | 10.46% |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589 |
Medical Distribution | -4.18% |
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.06% |
|
BCM Alliance Bhd
KLSE:0187 |
Medical Distribution | 17.12% |
|
Qingdao Baheal Medical INC.
SHE:301015 |
Medical Distribution | 3.50% |
|
Excelsior Medical Co Ltd
TW:4104 |
Medical Distribution | 3.70% |
|
CHC Healthcare Group
TW:4164 |
Medical Distribution | 0.46% |
Annual Asset Resilience Ratio for Millennium Pharmacon International (2000–2021)
The table below shows the annual Asset Resilience Ratio data for Millennium Pharmacon International.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2021-12-31 | -1.73% | Rp-20.88 Billion | Rp1.21 Trillion | +0.54pp |
| 2020-12-31 | -2.27% | Rp-26.47 Billion | Rp1.16 Trillion | +0.39pp |
| 2019-12-31 | -2.66% | Rp-32.71 Billion | Rp1.23 Trillion | -1.24pp |
| 2018-12-31 | -1.42% | Rp-16.91 Billion | Rp1.19 Trillion | +0.27pp |
| 2017-12-31 | -1.69% | Rp-15.86 Billion | Rp938.01 Billion | -1.71pp |
| 2002-12-31 | 0.01% | Rp15.90 Million | Rp108.27 Billion | -2.88pp |
| 2000-12-31 | 2.89% | Rp3.28 Billion | Rp113.38 Billion | -- |